logo2

Publications of Yu-Chen Hu (胡育誠)

*: Corresponding author; IF: 2024 Impact factor

A.   Journal Papers (* Corresponding author)

Submitted and in press

  1. Dang, Q.T., Chang, C.-W,, Dung, K.T.N., Truong, V.A., Huang, P.-Y., Hu, Y.-C.*. Optimized CRISPR-associated transposon for viral vector engineering and prime editing. Submitted.

  2. Truong, V.A., Le Thi, X-M, Huang, S.-C., Dang, Q. T., Nguyen, M.T.T., Hu, Y.-C.*. Coupling hfCas13d with circular gRNA array extends RNA knockdown and improves biocatalysis in the yeast.  Submitted to Nature Communications. Revision under review.

  3. Tien, T.-L, Chen, Chen, P.-Y., Chen, P.-H., Nguyen, N.T.K., Dang, Q.T., Truong, V.A., Hu, Y.-C.*.  Engineering human PEG10-based nanoparticles for RNA self-packaging, delivery and cancer therapy. Submitted to Nature Communications. Revision under review.

  4. Yang, S.-W., Liao, M.-F., Wang, T.-W., Hung, Y.-H., Lee, Y.-L., Dang, Q.-T., Chen, P.-Y., Ro, L.-S*, and Y.-C. Hu*. RNA-guided activation of IL-10 in adipose-derived stem cells regulates inflammation and attenuates neuropathic pain. Submitted.

  5. Chiang, C.-W., Tung, Y-T., Huang, S.-C., Chen, Y.-C., Shah, P., X. M. Le Thi, V. A. Truong, Hu, Y.-C*.  Green Synthesis of w-hydroxydodecanoic acid by engineering C. viswanathii with Cas13d. Green Chemistry, Revision under review.

    2024

  6. Truong, V.A., Chang, Y.H., Dang, T.Q., Tu, Y., Tu, J., Chang, C.-W., Chang, Y.H., Hu, Y.-C.*. 2024. Sep. Programmable editing of primary microRNA switches stem cell differentiation and improves tissue regeneration. Nature Communications. 15:8358 (IF 14.7).

  7. Chang, C.-W., Truong, V.A., Pham, N.N, Hu, Y.-C.*. 2024. Aug. RNA-guided genome engineering: paradigm shift towards transposons. Trends in Biotechnology. 42: 970-985 (IF 14.3). Review paper

  8. Nguyen, NTK, Lee, H.-S., P.-H. Chen, Truong, V.A., Chang, Y.-H., Pham, N.N., Chang, C.-W., Pham, D.-H., Ngo, DKT, Truong, V.A., Dang, Q.T., Chang, Y.-H., Hu, Y.-C.*. 2024 May. Enhanced calvarial bone repair using ASCs engineered with RNA-guided Split dCas12a system that co-activates Sox5, Sox6 and long non-coding RNA H19. Small. 20: 2306612 (Invited paper, IF 13).

  9. Pham, N.N., Wu, Y.H., Dai, T.A. Tu, J., Liang, R.-M., Hsieh, H.-Y., Chang, C.-W., Hu, Y.-C.*. 2024 Sep. Auto-inducible synthetic pathway in E. coli enhanced sustainable indigo production from glucose. Metabolic Engineering. 85: 14-25 (IF 6.8).

    2023

  10. Nguyen, NTK, Tu, Y., Lee, H.-S., Truong, V.A., Chang, Y.-H., Pham, N.N., Chang, C.-W., Lin, Y-H., Lai, P.-L., Chen, P.-H., Parfyonova, Y.V., Menshikov, M., Chang, Y.-H., Hu, Y.-C.*. 2023 June Split dCas12a activator for lncRNA H19 activation to enhance BMSC differentiation and promote calvarial bone healing. Biomaterials. 297:122106. (IF 12.8).

  11. Pham, N. N., Chang, C.-W., Chang, Y.-H., Tu, Y., Chou, J.-J., Wang, H.Y. and Hu, Y.-C.*. 2023 May. Rational genome and metabolic engineering of Candida viswanathii by split CRISPR to produce hundred grams of dodecanedioic acid. Metabolic Engineering. 77:76-88. (IF 6.8).

  12. Chang, C.-W., Huang, J.-W., Lu, Y.-H., Pham, N. N., Tu, J., Tung, Y.-T., Yen, C.-Y., Shen C.-C. Chien, M.-C. Tu, Y., Lin, Y.-H., Yang, S.-W., Nguyen, M.T.T. and Hu, Y.-C.*. 2023 March. Metabolic engineering of difficult-to-edit E. coli to enhance protein production by coupling ShCAST-based optimized transposon system and CRISPR interference. Journal of the Taiwan Institute of Chemical Engineers. 144: 104746 (IF 5.5).

  13. Michurina, S., Stafeev, I., Boldyreva, M., Truong, V.A., Ratner, E., Menshikov, M., Hu, Y.-C., Parfyonova, Y. 2023 Feb. Transplantation of adipose tissue-engineered constructs with CRISPR-mediated UCP1 activation. International Journal of Molecular Sciences. 24: 3844 (IF 4.9)

    2022

  14. Truong, A.V., Lin, Y.-H., Nguyen, TKN, Hsu, M.-N., Pham, N.N., Chang, Y.-H., Chang, C.-W., Shen, C.-C., Lai, P.-L., Parfyonova, Y.V., Menshikov, M., Wu, J.-C., Chang, Y.-H., Hu, Y.-C.*. 2022 Jan. Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats. Molecular Therapy. 30: 92-104. (IF 12.1).

  15. Chang, C.-W., Wang, L.-S., Pham, N. N., Shen C.-C., Nguyen, TKN, Yen, C.-Y., Lin, M.-W., Hsu, M.N., Nguyen, M.T.T., Hwu, J.-R., Chang, Y.-H. and Hu, Y.-C.*. 2022. Feb. Synthetic biology approach to developing all-in-one baculovirus vector using mammalian introns and miRNA binding sites. Journal of the Taiwan Institute of Chemical Engineers. 131: 104175. (IF 5.5).

  16. Li, H., Pham, N.N., Shen, C.R., Chang, C.-W., Tu, Y., Chang, Y.-H., Tu, J., Nguyen, M.T.T., Hu, Y.-C*. 2022 June. Combinatorial CRISPR interference library for enhancing 2,3-BDO production and elucidating key genes in cyanobacteria. Frontiers in Bioengineering and Biotechnology, 10:913820 (IF 4.3).

  17. Makarevich, P.I* and Hu, Y.-C. 2022. Editorial: Regulation of adult stem cells fate and function in natural and artificial microenvironments. Frontiers in Cell and Developmental Biology,10:955568 (IF 4.6).

  18. Liu, Y.-C., Hu, Y.-C., Chu, I.-M., Wei, Y.-H., Tsai, S.-L*. 2022 Feb. Biodegradation of tetramethylammonium chloride wastewater and inorganic nitrogen removal by a mixed culture. Journal of Environmental Chemical Engineering. 10: 106931. (IF 7.4)

  19. Stafeev, I.S., Boldyreva, M.A., Michurina, S.S., Agareva, M.Y., Radnaeva, A.V., Menshikov, M.Y., Hu, Y.-C., Makarevich, P.I., Parfyonova, Y. 2022 Nov. Impaired glucose tolerance and efficacy of HGF/VEGF gene therapy for limb ischemia: shift from angiogenesis to axonal growth and oxidative potential in skeletal muscle. Cells. 11: 3824 (IF 5.1).

  20. Hwu, J.-R., Kapoor, M., Gupta, N.K., Tsay, S.-C., Huang, W.-C., Tan, K.-T., Hu, Y.-C., Lyssen, P., Neyts, J. 2022 Mar. Synthesis and antiviral activities of quinazolinamine–coumarin conjugates toward chikungunya and hepatitis C viruses. European Journal of Medicinal Chemistry. 232:114164 (IF 6.0)

    2021

  21. Nguyen, TKN, Chang, Y.-H., Truong, A.V., Hsu, M.-N., Pham, NN, Chang, C.-W., Wu, Y.-H.,Chang, Y.-H., Li, H., Hu, Y.-C.*. 2021 Aug. CRISPR activation of long non-coding RNA DANCR promotes bone regeneration. Biomaterials. 275: 120965 (IF 12.8).

  22. Klionsky, D., Abdel-Aziz, A.K., ..Hu, Y.-C., et al. 2021 Feb. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 17:1-382. (IF 14.6,High Cite Paper, WOS Hot paper). Review paper.

  23. Chang, Y.-H., Lin, M.-W., Chien, M.-C., Ke, G.-M., Wu, I.-E., Lin, R.-L., Lin, C.-Y., Hu, Y.-C*. 2021 Oct. Polyplex nanomicelle delivery of self-amplifying RNA vaccine. Journal of Controlled Release. 338: 694-704. (IF 10.5, Invited paper.).

  24. Lin, M.-W., Shen, C.-C., Lin, Y.-J., Chou, M.-Y., Pham, N.-N., Chang, Y.-H., Chang, C.-W., Hwu, J.-R., Nguyen, M.T.T., Hu, Y.-C.*. 2021 April. Enhancing the yield and activity of defucosylated antibody produced by CHO-K1 cells using Cas13d-mediated multiplex gene targeting. Journal of the Taiwan Institute of Chemical Engineers.121: 38-47. (IF 5.5, selected as Best paper).

  25. Hwu, J.-R., Panja, A., Gupta, N.K., Huang, W.-C., Hu, Y.-C., Lin, C.-C., Hwang, K.-C., Chan, W.-J., Tsay, S.-C. 2021 April. Asymmetric synthesis of 3-pyrrolines through an aryne-induced domino process. Asian Journal of Organic Chemistry. 10: 803-815 (IF 2.8).

  26. Hwu, J.-R., Panja, A., Gupta, N.K., Hu, Y.-C., Tan, K-T., Lin, C.-C., Hwang, K.-C., Hsu, M.-H., Huang, W.-C., Tsay, S.-C. 2021 Jan. Domino Processes of Arynes Reacting with Three Classes of Nucleophiles for Organic Syntheses. European Journal of Organic Chemistry. 4: 683-693. (IF 2.5).

    2020

  27. Hsu, M.-N., Yu, F.-J., Chang, Y.-H., Huang, K-L., Pham, N. N., Troung, A.V., Lin, M.-W., Nguyen, N.T.K., Hwang, S.-M., Hu, Y.-C.* 2020 Sep. CRISPR interference-mediated Noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials. 252: 120094. (IF 12.8).

  28. Hsu, M.-N, Huang, K-L., Yu, F.-J., Lai, P.-L., Troung, A.V., Lin, M.-W., Nguyen, N.T.K., Shen, C.-C., Hwang, S.-M., Chang, Y.-H., Hu, Y.-C.* 2020 Feb. Co-Activation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSCs osteogenesis and promotes calvarial bone regeneration. Molecular Therapy 28: 441-451 (IF 12.1).

  29. Pham, N. N., Chen, C.-Y., Li, H., Nguyen, M.T.T., Nguyen, K.P.P., Tsai, S.-L., Chou, J.-Y., Ramli, T.C., Hu, Y.-C*. 2020 April. Engineering stable Pseudomonas Putida S12 by CRISPR for 2,5-furandicarboxylic acid (FDCA) production. ACS Synthetic Biology. 9: 1138-1149 (IF 3.7).

  30. Shen, C.-C., Lin, M.-W., Nguyen, B.K.T., Chang, C.-W., Shih, J.-R., Nguyen, M.T.T., Chang, Y.-H., Hu, Y.-C.*. 2020 Sep. CRISPR-Cas13d for gene knockdown and engineering of CHO cells. ACS Synthetic Biology. 9, 2808–2818 (IF 3.7).

  31. Srinivaas, M., Wu, C.-Y., Duh, J.-G., Hu, Y.-C., Wu, J.-M. 2020 Jan. Multi-walled carbon nanotubes decorated tungsten ditelluride nanostars as anode material for lithium-ion batteries. Nanotechnology 31: 035406 (IF 2.9).

  32. Hwu, J.-R., Panja, A. Jayakumar, S., Tsay, S-C., Tan, K.-T., Huang, W.-C., Hu, Y.-C., Leyssen, P., Neyts, J. 2020 Aug. Enterovirus inhibition by hinged aromatic compounds with polynuclei. Molecules. 25:3821. (IF 4.2)

  33. Oh, M-K, Sakai, Y., Hu, Y.-C. 2020 June. Asian Congress on Biotechnology 2019. Biotechnology Journal. 2020, 15: 2000214. (IF 3.2)

  34. Hwu, J.-R., Roy, A, Panja, A., Huang, W.-C., Hu, Y.-C., Tan, K.-T., Lin, C.-C., Hwang, K.-C., Hsu, M.-H., Tsay, S.-C. 2020 Aug. Domino reaction for the synthesis of polysubstituted pyrroles and Lamellarin R. Journal of Organic Chemistry. 85: 9835-9843. (IF 3.3).

    2019

  35. Hsu, M-N., Chang, Y.-H., Truong, V. A., Nguyen, N.T.K., Hu, Y.-C.* 2019 Dec. CRISPR technology for stem cell engineering and regenerative medicine. Biotechnology Advances 37:107447. (IF 12.1). (Review paper)

  36. Hsu, M.-N., Hu, Y.-C.*. Local magnetic activation of CRISPR. 2019 Feb. Nature Biomedical Engineering. 3: 83-84. (IF 26.8).

  37. Truong, V. A., Hsu, M-N., Nguyen, N.T.K., Lin, M-W., Shen, C.-C., Lin, C.-Y., Hu, Y.-C.* 2019. July. CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucleic Acids Research. 47: e74 (IF 16.6).

  38. Shen, C.-C., Hsu, M.-N., Chang, C.-W., Lin, M.-W., Hu, Y.-C*. 2019 Feb. Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation. Nucleic Acids Research. 47: e13 (IF 16.6).

  39. Hsu, M-N., Liao, H.-T., Truong, V. A., Huang, K.-L., Yu, F.-J., Chen, H.-H., Nguyen, N.T.K., Makarevich P., Parfyonova, Y., Hu, Y.-C.* 2019 Aug. CRISPR-based activation of endogenous neurotrophic genes in adipose stem cell sheets to stimulate peripheral nerve regeneration. Theranostics. 9: 6099-6111 IF 12.4).

  40. Wang, S.-Y., Chen, C.-L., Hu, Y.-C., Chi, Y., Huang, Y.-H., Su, C.-W., Jeng, W.-J., Liang, Y.-J., Wu, J.-C*. 2019 Oct. High expression of microRNA-196a is associated with progression of hepatocellular carcinoma in younger patients. Cancers. 11: 1549 (IF 4.5).

  41. Sung, L.-Y., Wu, M.-Y., Lin, M.-W., Hsu, M.-N., Troung, V. A., Shen, C.-C., Tu, Y., Hwang, K.-Y., Tu, A. P., Chang, Y.-H., Hu, Y.-C.*. 2019 May. Combining orthogonal CRISPR and CRISPRi systems for genome engineering and metabolic pathway modulation in E. coli. Biotechnology and Bioengineering. 116: 1066-1079 (IF 3.5).

  42. Hwu, J.-R., Huang, W.-C., Lin, S.-Y., Tan, K.-T., Hu, Y.C., Shieh, F.-K., Bachurin, S.O., Ustyugov A, Tsay, S.-C. 2019 March. Chikungunya virus inhibition by synthetic coumarin-guanosine conjugates. Eur J Med Chem 166: 136-143. (IF 6.0).

  43. Shevchenko M. B. E., Molokotina, Y. M., Makarevich, P., Beloglazova, I., Zubkova, E., Dergilev, K., Tsokolaeva, Z., Penkov, D., Hsu, M.-N., Hu, Y.-C., Parfyonova, Y. 2019 June. Transplantation of adipose stromal cell sheet producing hepatocyte growth factor induces pleiotropic effect in ischemic skeletal muscle. International Journal of Molecular Sciences. 20: 3088. (IF 4.9)

    2018

  44. Lin, M.-W., Tseng, Y.-W., Shen, C.-C., Hsu, M.-N., Hwu, J.-R., Chang, C.-W., Yeh, C.-J., Chou, M.-Y., Wu, J.-C., Hu, Y.-C.*. 2018, Sep. Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells. Nucleic Acids Research. 46: e93 (IF 16.6).

  45. Lin, K.-C., Lin, M.-W., Chen, G.-Y., Chao, Y.-C., Tuan, H.-Y., Chiang, C.-S., Hu, Y.-C.*. 2018 March. Graphene oxide chemosensitizes cancer cells to cisplatin by inducing early autophagy events, promoting nuclear trafficking and necrosis. Theranostics 8: 2477-2487 (IF 12.4).

  46. Masimukku, S., Hu, Y.-C., Lin, Z.-H., Chan, S.-W., Chou, T.-M., Wu, J.-M. 2018 April. High efficient degradation of dye molecules by PDMS embedded abundant single-layer tungsten disulfide and their antibacterial performance. Nano Energy. 46: 338-346. (IF 16.8).

  47. Lin, C.-W., Cheng, M.-C., Lin, S.-Y., Hung, S.-H., Jhang, S.-Y., Chang, C.-W., Cheng, P.-C., Hu, Y.-C.*. 2018 Oct. Hybrid baculovirus–mediated prolonged hemagglutinin expression and secretion in vivo enhances the vaccine efficacy. Journal of the Taiwan Institute of Chemical Engineers. 91: 47-56 (IF 5.5).

  48. Lin, S.-Y., Sung, L.-Y., Yeh, C.-T., Yu, C.-P., Yang, J.-Y., Hu, Y.-C.*. 2018 Jan. Production and purification of virus-like particles of different enterovirus subtypes as vaccines. Journal of the Taiwan Institute of Chemical Engineers. 82:1-9 (IF 5.5).

    1997 - 2017

  49. Hsu, M.-N., Liao, H.-T., Li, K.-C., Chen, H.-H., Yen, T.-C., Makarevich, P., Parfyonova, Y., Hu, Y.-C.*. 2017 Sep.  Adipose-derived stem cell sheets functionalized by hybrid baculovirus for prolonged GDNF expression and improved nerve regeneration. Biomaterials. 140: 189-200 (IF 10.273).

  50.  Lo, S.-C., Li, K.-C., Chang, Y.-H., Hsu, M.-N., Sung, L.-Y., Troung, A.V., Hu, Y.-C*. 2017 April. Enhanced critical-size calvarial bone healing by ASCs engineered with Cre/loxP-based hybrid baculovirus. Biomaterials. 124: 1-11 (IF 10.273).

  51. Wu, M.-Y., Sung, L.-Y., Li, H., Huang, C.-H., Hu, Y.-C.*. 2017 Dec. Combining CRISPR and CRISPRi systems for metabolic engineering of E. coli and 1,4-BDO biosynthesis. ACS Synth Biol. 6: 2350-2361 (IF 5.571).

  52. Shen, C.-C., Sung, L.-Y., Lin, S.-Y., Hu, Y.-C.*. 2017. Aug. Enhancing protein production yield from CHO cells by CRISPR interference (CRISPRi). ACS Synth. Biol. 6:1509-1519 (IF 5.571).

  53. Li, K.-C., Chang, Y.-H., Hsu, M.-N., Lo, S.-C., Li, W.-H., Hu, Y.-C*. 2017 Nov. Baculovirus-mediated miR-214 knockdown shifts osteoporotic ASCs differentiation and improves osteoporotic bone defects repair. Scientific Reports. 7:16225 (IF 4.011).

  54. Li, K.-C., Chang, Y.-H., Lo, S.-.C., Sung, L.-Y., Liao, Y.-H., Hu, Y.-C*. 2017. Nov. Improved calvarial bone repair by hASCs engineered with Cre/loxP-based baculovirus conferring prolonged BMP-2 and miR-148b co-expression. J. Tissue Eng. Regen. Med. 11: 3068-3077 (IF 3.319).

  55. Chung, M.-E., Yeh, I.-H., Sung, L.-Y., Wu, M.-Y., Chao, Y.-P., Ng, I.-S., Hu, Y.-C*. 2017 Jan. Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9. Biotechnology Bioengineering. 114: 172-183 (IF 4.260, High Cite paper).

    2016

  56. Li, K.-C., Chang, Y.-H., Yeh, C.-L., Hu, Y.-C*. 2016 Jan. Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing microRNA sponges. Biomaterials. 74: 155-166 (IF 10.273).

  57. Li, H., Shen, C.R., Huang, C.-H., Sung, L.-Y., Wu, M.-Y., Hu, Y.-C.* 2016. Nov. CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production. Metab. Eng. 38: 293-302 (IF 7.808).

  58.   Li, K.-C., Chu, H.-C., Lin, Y., Tuan, H.-Y., Hu, Y.-C*. 2016 April. PEGylated copper nanowires as a novel phototheraml therapy agent. ACS Appl. Mater. Interfaces. 8: 12082-12090 (IF 8.456).

  59. Klionsky, D.J., Abdelmohsen, K., Hu, Y.-C., et al. 2016 Jan. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 12: 1-222. (IF 11.059, High Cite paper, WOS hot paper).

  60.  Huang, C.-H., Shen, C.R., Li, H., Sung, L.-Y., Wu, M.-Y., Hu, Y.-C.* 2016. Nov. CRISPR interference (CRISPRi) for gene regulation and succinate production in cyanobacterium S. elongatus PCC 7942. Microb. Cell Fact. 15: 196. (IF 4.402, invited paper)

    2015

  61.  Lin, C.-Y., Wang, Y.-H., Li, K.-C., Sung, L.-Y., Yeh, C.-L., Lin, K.-J., Yen, T.-C., Chang, Y.-H., Hu, Y.-C.*. 2015 May.  Healing of massive segmental femoral bone defects in minipigs by allogenic ASCs engineered with FLPo/Frt-based baculovirus vectors. Biomaterials. 50: 98-106. (IF 10.273).

  62. Chen, C.-L., Tseng, Y.-W., Wu, J.-C., Chen, G.-Y., Lin, K.-C., Hwang, S.-M.,  Hu, Y.-C.*. 2015 March. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and microRNA regulation. Biomaterials. 44: 71-81 (IF 10.273, High Cite paper).

  63. Chen, G.-Y., Meng, C.-L., Lin, K.-C., Tuan, H.-Y., Yang, H.-J., Chen, C.-L., Li, K.-C., Chiang, C.-S., Hu, Y.-C.*. 2015 Feb. Graphene oxide as a chemosensitizer: diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects. Biomaterials. 40: 12-22. (IF 10.273).

  64. Chen, C.-L., Wu, J.-W., Chen, G.-Y., Yuan, P.-H., Tseng, Y.-W., Li, K.-C., Hwang, S.-M., Hu, Y.-C.*. 2015. Jan. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol. Ther. 23: 79-88 (IF 8.402, High Cite paper).

  65.  Li, K.-C., Hu, Y-.C.*. 2015. May. Cartilage tissue engineering: Recent advances and perspectives from gene regulation/therapy. Adv. Healthcare Mater. 4: 948-968 (IF 6.270, invited Review).

  66. Makarevich, P.I, Boldyreva1, M.A., Gluhanyuk, E.V., Efimenko, A.Y., Dergilev, K.V., Shevchenko, E.K., Sharonov, G.V., Gallinger, J.O., Rodina, P.A., Sarkisyan, S.S., Hu, Y.-C., Parfyonova, Y.V.  2015. Oct. Enhanced angiogenesis in ischemic skeletal muscle after transplantation of cell sheets from baculovirus-transduced adipose-derived stromal cells expressing VEGF165. Stem Cell Research & Therapy. 6: 204. (IF 4.627)

  67.   Li, K.-C., Chang, Y.-H., Lin, C.-Y., Hwang, S.-M., Wang, T.-Z., Hu, Y-.C.*. 2015 May. Preclinical safety evaluation of ASCs engineered by FLPo/Frt-based hybrid baculovirus: In vitro and large animal studies. Tissue Eng. Part A. 21: 1471-1482 (IF 3.616).

  68. Lin, S-.Y., Yeh, C.-T., Li, W.-H., Yu, C.-P., Lin, W.-C., Yang, J.-Y., We, H.-L., Hu, Y.-C*. 2015 Oct. Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design. Biotechnol. Bioeng. 112: 2005-2015. (IF 4.260)

  69.   Lin, S.-Y., Chiu, H.-Y., Chiang, B.-L., Hu, Y.-C*. 2015 Nov. Development of EV71 virus-like particle purification processes. Vaccine. 33: 5966-5973. (IF 4.1)

    2014

  70. Sung, L.-Y., Chen, C.-L., Lin, S.-Y., Li, K.-C., Yeh, C.-L., Chen, G.-Y., Lin, C.-Y., Hu, Y.-C.*. 2014 Aug. Efficient gene delivery into cell lines and stem cells using baculovirus. Nature Protocol. 9: 1882-1899 (IF 13.1).

  71.  Liao, Y.-H., Chang, Y.-H., Sung, L.-Y., Li, K.-C., Yeh, C.-L., Yen, T.-C., Hwang, S.-M., Lin, K.-J., Hu, Y.-C.*. 2014. June. Enhanced ASCs osteogenesis and repair of calvarial defects by baculovirus-mediated co-expression of BMP-2 and miR-148b. Biomaterials. 35: 4901-4910 (IF 10.273).

  72. Yeh, T.-S., Fang, Y.-H. D, Lu, C.-H., Chiu, S.-C., Yeh, C.-L., Yen, T.-C., Parfyonova, Y., Hu, Y.-C.* 2014 Jan. Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction. Biomaterials. 35: 174-184 (IF 10.273).

  73. Lu, C.-H., Yeh, T.-S., Yeh, C.-L., Fang, Y.-H. D., Sung, L.-Y., Lin, S-.Y., Yen, T.-C., Chang, Y.-H., Hu, Y.-C*. 2014 Jan. Regenerating cartilages by engineered ASCs: Prolonged TGF-b3/BMP-6 expression improved articular cartilage formation and restored zonal structure. Mol. Ther. 22: 186-195 (IF 8.402).

  74. Chen, G.-Y., Chen, C.-L., Tuan, H.-Y., Yuan, P.-X., Li, K.-C., Yang, H.-J., Hu, Y.-C.*. 2014. Sep. Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo. Adv. Healthcare Mater. 3: 1486-1495. (IF 6.270).

  75.  Lin, C.-Y., Chang, Y.-H., Sung, L.-Y., Lu, C.-H., Chen, C.-L., Lin, S.-Y., Li, K.-C., Yen, T.-C., Lin, K.-J., Hu, Y.-C.*. 2014 May. Long-term tracking of segmental bone healing mediated by genetically engineered adipose-derived stem cells: Focuses on bone remodeling and potential side effects. Tissue Eng. Part A. 20: 1392-1402. (IF 3.616).

  76. Lin, S.-Y., Chung, Y.-C., Hu, Y.-C*. 2014. Dec. Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev. Vaccines. 13: 1501-1521 (IF 4.271, Invited Review).

  77. Lin, Y.-L., Hu, Y.-C., Liang, C.-C., Lin, S.-Y., Liang, Y.-C., Yuan, H.-P., Chiang, B.-L*. 2014 Oct. Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling. PLOS One. 9: e111496 (IF 2.776).

  78.  Lin, S.-Y., Chung, Y.-C., Chiu, H.-Y., Chi, W.-K., Chiang, B.-L., Hu, Y.-C.*. 2014 March. Evaluation of the stability of enterovirus 71 virus-like particle. J. Biosci. Bioeng. 117: 366-371 (IF 2.032).

  79.  Lu, C.-H., Chang, Y.-H., Li, K.-C., Hu, Y.-C*. 2013 Dec. Recent progresses in gene delivery-based bone tissue engineering.  Biotechnol. Adv. 31: 1695-1706 (IF 12.831).

    2013

  80. Lin, C.-Y., Chang, Y.-H., Li, K.-C., Lu, C.-H., Sung, L.-Y., Yeh, C.-L., Lin, K.-J., Huang, S.-F., Yen, T.-Z., Hu, Y.-C.*. 2013. Dec. The use of ASCs engineered to express BMP2 or TGF-b3 within scaffold constructs to promote calvarial bone repair. Biomaterials. 34: 9401-9412 (IF 10.273).

  81. Sung, L.-Y., Chen, C.-L., Lin, S.-Y., Hwang, S.-M., Li, K.-C., Lan, A. S.-M., Hu, Y.-C*. 2013. Aug. Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: A comparative study. Nucleic Acids Res. 14: e139 (IF 11.147).

  82. Airenne, K.J., Hu, Y.-C., Kost, T.A., Smith, R.H., Kotin, R.M., Ono, C., Matsuura,Y., Wang, S. and Ylä-Herttuala, S. 2013. April. Baculovirus: An insect-derived vector for diverse gene transfer applications.   Mol. Ther. 21: 739-749. (IF 8.402, High Cite paper, invited review)

  83.  Luo, W.-Y., Lin, S.-Y., Lo, K.-W., Hung, C.-L, Chen, C.-Y., Chang, C.-C., Hu, Y.-C.*. 2013 May. Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo. J. Virol. 87: 4965-4973 (IF 4.324).  

  84. Chen, C.-Y., Lin, S.-Y., Cheng, M.-C., Tsai, C.-P., Hung, C.-L., Lo, K.-W., Huang, Y., Hu, Y.-C.*. 2013. Mar. Baculovirus vector as the avian influenza vaccine: Enhanced hemagglutinin expression and presentation augment the vaccine immunogenicity. J. Biotechnol. 164: 143-150. (IF 3.163)

    2012

  85.   Lin, C.-Y., Lin, K.-J., Li, K.-C., Sung, L.-Y., Hsueh, S., Lu, C.-H., Chen, G.-Y., Chen, C.-L., Huang, S.-F., Yen, T.-C., Chang, Y.-H., Hu, Y.-C.* 2012. Oct. Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs. Biomaterials. 33: 7422-7434 (IF 10.273). 

  86.   Chen, G.-Y., Yang, H.-J., Lu, C.-H., Chao, Y.-.C., Hwang, S.-M., Chen, C.-L., Lo, K.-W., Sung, L.-Y., Luo, W.-Y., Tuan, H.-Y., Hu, Y.-C*.2012. Sep. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials. 33: 6559-6569 (IF 10.273).

  87. Lin, C.-Y., Chang, Y.-H., Kao, C.-Y., Lu, C.-H., Sung, L.-Y., Yen, T.-C., Lin, K.-J., Hu, Y.-C.*.  2012 May. Augmented healing of critical-size calvarial defects by baculovirus-engineered mesenchymal stem cells that persistently express growth factors. Biomaterials. 33: 3682-3692 (IF 10.273)

  88. Chen, G.-Y., Pang, D. W.-P., Hwang, S.-M., Tuan, H.-Y.*, Hu, Y.-C.*. 2012 Jan. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials. 33: 418-427. (IF 10.273, High Cite paper)

  89. Chen, G.-Y., Hwang, S.-M., Su, H.-J., Kuo, C.-Y., Luo, W.-Y., Lo, K.-W., Huang, C.-C., Chen, C.-L., Yu, S.-H., Hu, Y.-C*. 2012. Aug. Defective antiviral responses of induced pluripotent stem cells to viral vector transduction. J. Virol. 86: 8041-8049

  90.   Lu, C.-H., Lin, K.-J., Chiu, H.-Y., Chen, C.-Y., Yen, T.-C., Hwang, S.-M., Chang, Y.-H., Hu, Y.-C.* 2012. Oct. Improved chondrogenesis and engineered cartilage formation from TGF-b3-expressing adipose-derived stem cells cultured in the rotating-shaft bioreactor. Tissue Eng. Part A. 18: 2114-2124.  

  91. Luo, W.-Y., Shih, Y.-S., Hung, C.-L., Chiang, C.-S., Lo, W.-H., Huang, S.-F., Wang, S.-C., Yu, C.-F., Chien, C.-H., Hu, Y.-C.*. 2012. Aug. Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy. Gene Ther. 19: 844-51.

  92.   Lin, Y.-L., Yu, C.-I., Hu, Y.-C., Tsai, T.-J., Kuo, Y.-C., Chi, W.-K., Lin, A.-N., Chiang, B.-L. 2012. Feb. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.  Vaccine  30: 1305-1312.

  93. Hu, Y.-C.*, Chen, S.-C. 2012. April. Taiwan’s chemical industry: looking back and looking ahead. Chem. Eng. Prog. 108: 41-46. (Invited review)

    2011

  94.  Lin, C.-Y., Lin, K.-J., Kao, C.-Y., Chen, M.-C., Yen, T.-Z., Lo, W.-H., Chang, Y.-H., Hu, Y.-C.*. 2011 Sep. The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials. 32: 6505-6514. (IF 10.273)

  95. Chen, C.-Y., Lin, C.-Y., Chen, G.-Y. Hu, Y.-C*. 2011 Nov. Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications.  Biotechnol. Adv. 29: 618-631 (IF 12.831).

  96. Chen, C.-Y., Wu, H.-H., Chen, C.-P., Chern, S.-R., Hwang, S.-M, Huang, S.-F., Lo, W.-H., Chen, G.-Y., Hu, Y.-C.*. 2011 Oct. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Molecular. Pharmaceutics. 8: 1505-1514.

  97. Chen, C.-L., Luo, W.-Y., Lo, W.-H., Lin, K.-J., Sung, L.-Y., Shih, Y.-S., Chang, Y.-H., Hu, Y.-C*. 2011. Dec. Development of hybrid baculovirus vectors for artificial microRNA delivery and sustained gene suppression. Biotechnol. Bioeng. 108: 2958-2967 (selected as the Spotlight paper and invited for Video Abstract). 

  98. Luo, W.-Y., Shih, Y.-S., Lo, W.-H., Chen, H.-R., Wang, S.-C., Wang, C.-H., Chien, C.-H., Chiang, C.-S., Chuang, Y.-J., Hu, Y.-C.*. 2011. Baculovirus vectors for antiangiogenesis-based cancer gene therapy. Cancer Gene Ther. 18:637-645.

  99. Kamen, A.A., Aucoin, M.G., Merten, O-W, Alves, P., Hashimoto, Y., Airenne K., Hu, Y.-C., Mezzina, M., van Oers, M.M.. 2011. July. An initiative to manufacture and characterize baculovirus reference material. J. Invertebr Pathol. 107:S113-S117.

  100. Lo, W.-H., Chen, C.-Y., Yeh, C.-N., Lin, C.-Y., Hu, Y.-C.* 2011. Rapid baculovirus titration based on regulatable green fluorescent protein expression in mammalian cells. Enzyme Microb. Technol. 48: 13-18.

  101. Lin, S.-Y., Chen, G.-Y., Hu, Y.-C.*. 2011. Recent patents on the baculovirus systems. Recent Patents on Biotechnol. 5: 1-11. (Invited contribution).

    1997-2010

  102.  Lin, C.-Y., Chang, Y.-H., Lin, K.-J., Yen, T.-Z., Tai, C.-L., Chen, C.-Y., Lo, W.-H., Hsiao, I.-T., Hu, Y.-C.*. 2010 Apr. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells.  Biomaterials. 31: 3222-3230.

  103. Lin, C.-Y., Lu, C.-H., Luo, W.-Y., Chang, Y.-H., Sung, L.-Y., Chiu, H.-Y., Hu, Y.-C.*. 2010 Jun. Baculovirus as a gene delivery vector for cartilage and bone tissue engineering.  Curr. Gene Ther. 10: 242-254. (Invited Review).

  104. Hu, Y.-C*. 2010 Jun. Baculovirus: a promising vector for gene therapy? Curr Gene Ther. 10:167.

  105. Chen, C.-Y., Liu, H.-J., Tsai, C.-P., Chung, C.-Y., Shih, Y.-S., Chang, P.-C., Hu, Y.-C*.  2010. Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms. Vaccine. 28: 7644-7651.

  106. Chung, C.-Y., Chen, C.-Y., Lin, S.-Y., Chung, Y.-C., Chiu, H.-Y., Chi, W.-K., Lin, Y.-L., Chiang, B.-L., Chen, W.-J., Hu, Y.-C.* 2010. Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield. Vaccine. 28:6951-6957.

  107. Chuang, C.-K., Lin, K.-J., Lin, C.-Y., Chang, Y.-H., Yen, T.-C., Hwang, S.-M., Sung, L.-Y., Chen, H.-C., Hu, Y.-C.*. 2010.  Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair. Tissue Eng. Part A. 16:479-488.

  108. Chen, H.-C., Chang, Y.-H., Chuang, C.-K., Lin, C.-Y., Sung, L.-Y., Wang, Y.-H., Hu, Y.-C.* 2009 Feb. The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials. 30: 674-681.

  109.  Chuang, C.-K., Wong, T.-H., Hwang, S.-M., Chang, Y.-H., Chen, Y.-H., Chiu, Y.-C., Huang, S.-F., Hu, Y.-C.*. 2009 May. Baculovirus transduction of mesenchymal stem cells: In vitro responses and in vivo immune responses after cell transplantation. Mol. Ther. 17: 889-896.

  110. Lo, W.-H., Hwang, S.-M., Chuang, C.-K., Chen, C.-Y., Hu, Y.-C.*. 2009 Apr. Development of a hybrid baculoviral vector for sustained transgene expression. Mol. Ther. 17:658-666.

  111. Chen, G.-Y., Shiah, H.-C., Su, H.-J., Chen, C.-Y., Chuang, Y.-J., Lo, W.-H., Huang, J.-L., Chuang, C.-K., Hwang, S.-M., Hu, Y.-C.* 2009. Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 (TLR3) pathway. J. Virol. 83: 10548-10556.

  112. Sung, L.-Y., Chiu, H.-Y., Chen, H.-C., Chen, Y.-L., Chuang, C.-K., Hu, Y.-C.*. 2009. Baculovirus-mediated growth factors expression in de-differentiated chondrocytes accelerates re-differentiation: Effects of combinational transduction. Tissue Eng. Part A. 15:1353-1362.

  113. Lee, H.-P., Matsuura, Y., Chen, H.-C., Chen, Y.-L., Chuang, C.-K., Abe, T., Hwang, S.-M., Shiah, H.-C., Hu, Y.-C*. 2009. Baculovirus transduction of chondrocytes elicits interferon-a/b and suppresses transgene expression. J. Gene Med. 11: 302-312.

  114. Lin, Y.-J., Yen, C.-N., Hu, Y.-C., Wu, Y.-C., Liao, C.-J., Chu, I.-M. 2009. Chondrocytes culture in three-dimensional porous alginate scaffolds enhanced cell proliferation, matrix synthesis and gene expression. J. Biomed. Mater. Res. A. 88: 23-33.

  115. Chen, Y.-L., Tuan, H.-Y., Tien, C.-W., Lo, W.-H., Liang, H.-C., Hu, Y.-C*. 2009. Augmented biosynthesis of cadmium sulfide nanoparticles by genetically engineered Escherichia coli. Biotechnol. Prog. 25:1260-1266.

  116.  Chen, G.-Y., Chen, C.-Y., Chang, M. D.-T., Matsuura, Y., Hu, Y.-C*. 2009. Concanavalin A affinity chromatography for efficient baculovirus purification. Biotechnol. Prog. 25: 1669-1677.

  117. Hu, Y.-C.*. 2008. Baculoviral vectors for gene delivery: A review. Curr. Gene Ther. 8: 54-65. (Invited Review). 

  118. Hu, Y.-C*, Yao, K., Wu, T.-Y., 2008. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert. Rev. Vaccines. 7: 363-371. (Invited Review).

  119. Chen, H.-C., Sung, L.-Y., Lo, W.-H., Chuang, C.-K., Wang, Y.-H., Lin, J.-L., Hu, Y.-C.*, 2008. Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther. 15: 309-317. 

  120. Chung, Y.-C., Ho, M.-S., Wu, J.-C., Chen, W.-J., Huang, J.-H. Chou, S.-T., Hu, Y.-C.*. 2008. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine. 26: 1855-1862.

  121.   Lin, Y-H., Lee, L.-H., Shih, W.-L., Hu, Y.-C., Liu, H.-J.  2008. Baculovirus surface display of sC and sB proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model. Vaccine. 26:6361-6367.

  122. Chen, Y.-L., Chen, H.-C., Chan, H.-Y., Chuang, C.-K., Chang, Y.-H., Hu, Y.-C.*. 2008. Co-conjugating chondroitin-6-sulfate/dermatan sulfate to chitosan scaffold alters chondrocyte gene expression and signaling profiles. Biotechnol. Bioeng. 101: 821-830.

  123. Shen, H.-C., Yeh, C.-N., Chen, G.-Y., Huang, S.-F., Chen, C.-Y., Chiu, Y.-C., Hu, Y.-C.*. 2008. Sustained baculovirus-mediated expression in myogenic cells. J. Gene Med. 10: 1190-1197.

  124.  Yen, C.-N., Lin, Y-R., Chang, M. D.-T., Tien, C.-W., Wu, Y.-C., Liao, C.-J., Hu, Y.-C.*. 2008. Use of porous alginate sponges for substantial chondrocyte expansion and matrix production: Effects of seeding density. Biotechnol. Prog. 24: 452-457.

  125. Chen, Y.-L., Lee, H.-P., Chan, H.-Y., Sung, L.-Y., Chen, H.-C., Hu, Y.-C.*. 2007. Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds for cartilage tissue engineering. Biomaterials. 28: 2294-2305.

  126. Sung, L.-Y., Lo, W.-H., Chiu, H.-Y., Chen, H.-C., Chuang, C.-K., Lee, H.-P., Hu, Y.-C.*. 2007. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials. 28: 3437-3447.

  127. Yang, D.-G., Chung, Y.-C., Lai, Y.-K., Lai, C.-W., Liu, H.-J., Hu, Y.-C.*. 2007. Avian influenza virus hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties and vaccine potential. Mol. Ther. 15: 989-996. 

  128. Huang, K.-S, Lo, W.-H., Chung, Y.-C., Lai, Y.-K., Chen, C.-Y., Chou, S.-T., Hu, Y.-C.*. 2007. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum. Gene Ther. 18:1161-1170.  

  129. Chuang, C.-K., Sung, L.-Y., Hwang, S.-M., Lo, W.-H., Chen, H.-C., Hu, Y.-C.*. 2007. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther. 14: 1417-1424.

  130.  Shen, H.-C., Lee, H.-P., Lo, W-H., Yang, D.-G., Hu, Y.-C.*. 2007. Baculovirus-mediated gene transfer is attenuated by sodium bicarbonate.  J. Gene Med. 9: 470-478..

  131.  Lee, H.-P., Chen, Y.-L., Shen, H.-C., Lo, W.-H., Ho, Y.-C., Hu, Y.-C.*. 2007. Baculovirus transduction of rat articular chondrocytes: Roles of cell cycle. J. Gene Med. 9: 33-43. 

  132. Lee, H.-P., Ho, Y.-C., Hwang, S.-M., Sung, L-.Y., Shen, H.-C., Liu, H.-J., Hu, Y.-C.*. 2007.  Variation of baculovirus-harbored transgene transcription among mesenchymal stem cell-derived progenitors leads to varied expression. Biotechnol. Bioeng. 97: 649-655 (Spotlight paper)

  133.   Tsai, C.-T., Chan, Z.-R., Lu, J.-T., Yang, D.-G., Lo, W.-H., Hu, Y.-C.* 2007. Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay. Enzyme Microb. Technol. 40: 1345-1351.

  134. Chiang, Y.-W., Wu, J.-C., Wang, K.-C., Chou, S.-T., Hu, Y.-C.* 2007. Varied properties of hepatitis-delta virus-like particles produced by baculovirus-transduced mammalian cells. Open Biotechnol. J. 1: 34-40. (Invited contribution).

  135. Hu, Y.-C.*, Chen, C.-Y., 2007. Recent patents on influenza vaccines. Recent Patents on Biotechnol. 1: 234-242. (Invited Review)

  136. Chen, H.-C., Lee, H.-P., Ho, Y.-C., Sung, M.-L., Hu, Y.-C*. 2006. Combination of baculovirus-mediated gene transfer and rotating-shaft bioreactor for cartilage tissue engineering.  Biomaterials. 27:3154-3162.

  137. Chen, Y.-L., Chen, H.-C., Lee, H.-P., Chan, H.-Y., Hu, Y.-C.*. 2006. Rational development of GAG-Augmented chitosan membranes by fractional factorial design methodology. Biomaterials. 27: 2222-2232.

  138.  Ho, Y.-C., Lee, H.-P., Hwang, S.-M., Lo, W.-H., Chen, H.-C., Chung, C.-K., Hu, Y.-C.* 2006. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther. 13: 1471-1479.

  139.  Lai, C.-W., Chan, Z.-R., Yang, D.-G., Lo, W.-H., Lai, Y.-K., Chang, M. D.-T., Hu, Y.-C*. 2006. Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. FEBS Lett. 580: 3829-3834.

  140.  Hu Y.-C., Luo, Y.-L., Ji, W-T, Chulua, J.L.C., Chang P.-C., Shieh, H., Wang, C.-Y., Liu, H.-J. 2006. Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system. J. Virol. Methods. 135: 43-48.

  141. Chiang, Y.-W., Wu, J.-C., Wang, K.-C., Lai, C.-W., Chung, Y.-C., Hu, Y.-C.* 2006. Efficient expression of histidine-tagged large hepatitis delta antigen in baculovirus-transduced BHK cells. World J. Gastroenterol. 12:1551-1557.

  142. Chung, Y.-C., Huang, J.-H., Lai, C.-W., Sheng, H.-C., Shih, S.-R., Ho, M.-S., Hu, Y.-C.* 2006. Expression, purification and characterization of enterovirus 71 virus-like particles. World J. Gastroenterol. 12: 921-927.

  143.  Chan, Z.-R., Lai, C.-W., Lee, H.-P., Chen, H.-C., Hu, Y.-C.*. 2006. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol. Bioeng. 93: 564-571.

  144. Chen, H.-C., Hu, Y.-C.* 2006. Bioreactors for tissue engineering: A review. Biotechnol. Lett. 28:1415-1423. (Invited Review)

  145. Ho, Y.-C., Chung, Y.-C., Hwang, S.-M., Wang, K.-C., Hu, Y.-C.* 2005. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J. Gene Med. 7:860-868.

  146. Chen, Y.-H., Wu, J.-C., Wang, K.-C., Chiang, Y.-W., Lai, C.-W., Chung, Y.-C., Hu, Y.-C.* 2005. Baculovirus-mediated production of HDV-like particles in BHK cells using a novel oscillating bioreactor. J. Biotechnol. 118:135-147.

  147.  Wang, K.-C., Wu, J.-C., Chung, Y.-C., Ho, Y.-C., Chang, M. D.-T., Hu, Y.-C.*. 2005. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol. Bioeng. 89: 464-473.

  148. Hu, Y.-C.* 2005. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol. Sin. 26: 405-416 (Invited Review, Most Highly Cited Paper Award)

  149. Lu, J.-T., Chung, Y.-C., Chan, Z.-R., Hu, Y.-C.* 2005. A novel oscillating bioreactor BelloCell: implications for insect cell culture and recombinant protein production. Biotechnol. Lett. 27: 1059-1065.

  150. Lai, C.-W., Chung, Y.-C., Lai, Y.-K, Chang, M. D.-T., Hu, Y.-C.* 2005. Expression and purification of N and E proteins from Severe Acute Respiratory Syndrome (SARS)-associated coronavirus: a comparative study. Biotechnol. Lett. 27: 883-891.

  151. Lee, H.-P., Chen, H.-C., Lai, C.-W., Chiang, S.-F., Liao, C.-J., Hu, Y.-C.* 2005. Eggshell as a novel biomimetic reactor for in vitro tissue culture. J. Chin. Inst. Chem. Engrs. 36:321-330. (Outstanding Paper Award, Chemical Engineering Society of Taiwan) 

  152. Ho, Y.-C., Chen, H.-C., Wang, K.-C., Hu, Y.-C.* 2004. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol. Bioeng. 88: 643-651.

  153. Hsu, C.-S., Ho, Y.-C., Wang, K.-C., Hu, Y.-C*. 2004. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol. Bioeng. 88:42-51.

  154. Chen, H.-C., Lee, H.-P., Sung, M.-L., Liao, C.-J., Hu, Y.-C.*. 2004. A novel rotating-shaft bioreactor for two-phase cultivation of tissue-engineered cartilage. Biotechnol. Prog. 20:1802-1809.

  155. Chung, Y.-C., Liu, H.-J., Hu, Y.-C.* 2004. Facile monitoring of avian reovirus σB expression and purification by tagged green fluorescent protein. Enzyme Microb. Technol. 35: 494-500.

  156. Hu, Y.-C.*, Tsai, C.-T., Chung, Y.-C., Lu, J.-T., Hsu, J. T-A. 2003. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb. Technol. 33:445-452.

  157. Hu, Y.-C.*, Tsai, C.-T., Chang, Y.-J., Huang, J.-H. 2003. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: Focuses on strategic infection and feeding. Biotechnol. Prog. 19:373-379.

  158. Hu, Y.-C.*, Hsu, J. T.-A., Huang, J.-H., Ho, M.-S., Ho, Y.-C. 2003. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol. Lett. 25: 919-925.

  159. Hu, Y.-C.*, Lu, J.-T., Chun, Y.-C. 2003. High-density cultivation of insect cells and production of recombinant baculovirus using a novel oscillating bioreactor. Cytotechnology. 42: 145-153.

  160. Hu, Y.-C.*, Liu, H.-J., Chung, Y.-C. 2002. High level expression of the key antigenic protein, σC, from avian reovirus into insect cells and its purification by immobilized metal affinity chromatography. Biotechnol. Lett. 24: 1017-1022.

  161.  Liu, H.-J., Kuo, L.-C., Hu, Y.-C., Liao, M.-H., Lien, Y.-Y. 2002. Development of an ELISA for detection of antibodies to avian reovirus in chickens. J. Virol. Methods. 102: 129-138.

  162.   Hu, Y.-C., Bentley, W.E. 2001. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: Deterministic predictions and experimental results. Biotechnol. Bioeng. 75: 104-119.

  163.   Hu, Y-C., Kaufman, J., Cho, M.W., Golding, H, Shiloach, J.  2000. Production of gp120 in packed-bed bioreactor using the vaccinia/T7 expression system.  Biotechnol. Prog. 16: 744-750.

  164. Hu, Y-C., Bentley, W.E.  2000.  A statistics and thermodynamics-based model for baculovirus infection and virus-like particle assembly.  Chem. Eng. Sci. 55:3991-4008.

  165. Hu, Y.-C., Bentley, W.E.  1999.  Enhancing yield of infectious bursal disease virus structural proteins in baculovirus expression system: Focus on media, protease inhibitors and dissolved oxygen.  Biotechnol. Prog. 15: 1065-1071.

  166. Hu, Y.-C., Vakharia, V.N., Edwards, G.H., Bentley, W.E. 1999. Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography.  Biotechnol. Bioeng. 63: 721-729.

  167. Naggie, S., Hu, Y.C., Pulliam-Holoman, T.R., Bentley, W.E. 1997. Substrate (gelatin) gel electrophoretic method for analysis of protease activity in insect (Sf-9) cells. Biotechnology Techniques 11: 297-300.

  168. Hu, Y.C., Wang, M-Y., Bentley, W.E. 1997. A tubular segmented-flow bioreactor for the infection of insect cells with recombinant baculovirus.  Cytotechnology 24: 143-152.

B.   Book Chapters (* Corresponding author)

  1. Wu, H.-C., Hu, Y.-C., Bentley, W.E. 2016. Tubular bioreactor for probing baculovirus infection and protein production. In “Baculovirus and Insect Cell Expression Protocols”. Volume 1350 of the series Methods in Molecular Biology (David Murhammer, Ed.) pp 461-467. Springer Protocols. Springer New York (ISBN-978-1-4939-3042-5)

  2. Lin, C.-Y., Chen, C.-L., Sung, L.-Y., Li, K.-C., Yeh, C.-L, Hu, Y.-C.*. 2015 Jan. Baculovirus as a gene delivery vector for bone and cartilage tissue engineering. In “Gene and Cell Therapy: Therapeutic Mechanisms and Strategies” 4th Ed. (Nancy, S. Templeton, Ed.), CRC Press/Taylor & Francis. p. 237-258 (ISBN-13: 9781466571990)

  3. Hu, Y.-C.*. 2014. Jan. Gene therapy for cartilage and bone tissue engineering. SpringerBriefs in Bioengineering.  Springer. (ISBN: 978-3-642-53922-0).

  4. Lo, W.-H., Hu, Y.-C*. 2010. Regulation of baculovirus-mediated gene expression.  In “Regulation of Viral Gene Expression” (Eli B. Galos, Eds), Nova Science Publishers, Hauppauge. p.279-298. (ISBN: 978-1-60741-224-3)

  5. Tsai, C.-T., Chuang, C.-K., Hu, Y.-C.*. 2009. Baculovirus-mediated gene transfer into mesenchymal stem cells. In “Viral Applications of the Green Fluorescent Protein” (Methods in Molecular Biology, Vol. 515) (Hicks, B., Ed.). Humana Press, Totowa, NJ. p. 339-351. (ISBN: 978-1-934115-87-9)

  6. Hu, Y.-C.*, Chuang, C.-K., Chang Y.-H. 2009. Gene therapy approach for cartilage engineering. In “Biotechnology and Bioengineering Research Trends” (Flynne, W.G., Ed.). Nova Science Publishers, Hauppauge. pp.121-143. (ISBN: 978-1-60456-067-1)

  7. Lee, H.-P., Hu, Y.-C.*. 2007. Expression in mammalian cells using BacMam viruses. In " Expression Systems” (Durocher, Y and Dyson, M., Eds.). pp. 261-275. Scion Publishing Limited, Oxfordshire. (ISBN: 978-1904842-43-9)

  8. Chung, Y.-C., Hu, Y.-C.*. 2007. Baculovirus expression vectors. In "Virus Expression Vectors" (Hefferon, KL, Ed.). pp. 319-338. Transworld Research Network (ISBN: 81-7895-273-4)

  9. Hu, Y.-C*., Bentley, WE*. 2007. Alternative molecular and reactor strategies probing infection and production. In "Baculovirus and insect cell expression protocols", (Methods in Molecular Biology, Vol. 388) 2nd Ed. (Murhammer DW, Ed.), Humana Press, Totowa, NJ. pp. 419-425. (ISBN: 1-58829-537-0)

  10. Hu, Y.-C.*. 2006. Baculovirus vectors for gene therapy. In "Insect Viruses: Biotechnological Applications" (Bonning BC, Ed.), Elsevier, New York. Advances in Virus Research  Vol. 68, pp. 287-320 (ISBN: 978-0-12-039868-3)

  11. 胡育誠, “生技醫藥”於吳文騰主編『生物產業技術概論』，清華大學出版社，新竹，pp 1-32.

  12. 胡育誠, “基因與蛋白質工程”於周更生主編『二十一世紀的新化學工程』，五南圖書出版公司，台北，pp 175-198.

C. Conference Presentations

  1. Hu, Y-C. 2022 Oct.  Keynote speaker and session chair, 2022 TERMIS-AP Meeting, Korea

  2. Hu, Y-C. 2022 Oct.  Invited speaker, 2022 Kyungpook National University Hospital (KNUH) International Conference. Daegu, Korea.

  3.  Chang, C.-W.; Hu, Y.-C. 2022 June. 27th BEST Conference & International Symposium on Biotechnology and Bioengineering. BEST oral presentation award. Taoyuan, Taiwan

  4.   Hu, Y-C. 2022 March.  Invited speaker, Annual meeting of FARM.  Taipei, Taiwan

  5. Hu, Y-C. 2021 Nov.  Keynote speaker and session chair, AFOB virtual conference, Korea

  6. Hu, Y-C., 2021 Oct. Keynote speaker. Annual Meeting of the Taiwan Neuroimmunology Medical Society and Society for Neurological Rare Disorders-Taiwan. Taipei, Taiwan.

  7. Hu, Y-C. 2021 July. Keynote speaker. The 26th BEST conference and International Symposium on Biotechnology and Bioengineering. Taichung. Taiwan.

  8. Hu, Y-C. 2021, June. Keynote speaker. 2021 Annual Meeting of Agricultural Chemical Society of Taiwan. Taipei, Taiwan.

  9. Hu, Y-C. 2020 Dec. Invited Speaker. Nanomicelle Delivery of Self-Amplifying mRNA as a Porcine Vaccine. International Conference on Emergent Functional Matter Science 2020.  Suao, Taiwan.

  10. Hu, Y-C., 2020 Aug. Gene Therapy for Tissue Regeneration. Keynote speaker. Annual Meeting of Biomaterials and Controlled Release Society in Taiwan.  Taipei, Taiwan.

  11. Hu, Y-C., 2019 Dec. CRISPR Technology for Tissue Regeneration. Keynote speaker. International Symposium of Gene Therapy for Hereditary Diseases.  Taipei, Taiwan

  12. Hu, Y-C., 2019 Oct. CRISPR Technology for Tissue Regeneration. Keynote speaker. TERMIS-AP meeting.  Brisbane, Australia.

  13. Hu, Y-C., 2019 July. CRISPR Technology for Tissue Regeneration. NTHU-SNU Bilateral Symposium. Seoul. Korea.

  14. Hu, Y-C., 2019 July. CRISPR Technology for Metabolic Engineering and Tissue Regeneration NTHU-VNU Bilateral Symposium. Ho Chi Minh City, Vietnam.

  15. Hu, Y.-C*. 2018 Sep. Delivery of anabolic genes, miRNA and CRISPR systems for stem cell fate modulation and tissue regeneration. Plenary speaker. TERMIS-World Congress. Kyoto, Japan.

  16. K.-L., Huang, M.-N., Hsu, Truong, Vu A., Hu, Y.-C*. 2018 Sep. CRISPR activation for stem cell engineering and enhanced calvarial bone healing. TERMIS-World Congress. Kyoto, Japan.

  17. M.-N., Hsu, K.-L., Huang, Truong, Vu A., Hu, Y.-C*. 2018 Sep. Adipose-derived stem cell sheets functionalized by hybrid baculovirus for prolonged GDNF expression and improved nerve regeneration. TERMIS-World Congress. Kyoto, Japan.

  18. Truong, Vu A., K.-L., Huang, M.-N., Hsu, Hu, Y.-C*. 2018 Sep. CRISPR-mediated dual programming of bone marrow-derived mesenchymal stem cell for calvarial bone defect regeneration. TERMIS-World Congress. Kyoto, Japan.

  19. C.-W., Chang, L.-S., Wang, C.-C., Shen, Hu, Y.-C*. 2018 Aug. Development and application of a new Cre/loxP-based long-term gene expression system in single recombinant baculovirus. Asian Federation of Biotechnology Malaysia Chapter International Symposiums 2018 (AFOBMCIS 2018), Sarawak, Malaysia.

  20. Hu, Y.-C*. 2018 Aug. Bacterial engineering and production of chemicals using CRISPR technology.  Plenary speaker. Cross-strait Chemical Engineering Forum. Taiyun, China.

  21. Hu, Y.-C*. 2018 July. Delivery of RNA therapeutics and CRISPR systems for stem cell engineering and tissue regeneration. Keynote speaker. European Congress of Biotechnology.  Geneva, Switzerland.

  22. M.-N., Hsu, Hu, Y.-C*. 2018 Jun. Adipose-derived stem cell sheets functionalized by hybrid baculovirus for prolonged GDNF expression and improved nerve regeneration. 2018 BEST Conference & International Symposium on Biotechnology and Bioengineering, Taipei, Taiwan.

  23. K.-L., Huang, Hu, Y.-C*. 2018 Jun. CRISPR activation for BMSC and ASC engineering and enhanced calvarial bone healing. 2018 BEST Conference & International Symposium on Biotechnology and Bioengineering, Taipei, Taiwan.

  24. C.-W., Chang, Hu, Y.-C*. 2018 Aug. Development and Application of A New Cre/loxP-based Long-Term Gene Expression System In Single Recombinant Baculovirus. 2018 BEST Conference & International Symposium on Biotechnology and Bioengineering, Taipei, Taiwan.

  25. M-W., Lin, Hu, Y.-C*. 2018 Jun. Synthetic Circuit-based Baculovirus for Transgene Expression Control and Selective Killing of Hepatocellular Carcinoma Cells. 2018 BEST Conference & International Symposium on Biotechnology and Bioengineering, Taipei, Taiwan

  26. C.-C., Shen, Hu, Y.-C*. 2018 Jun. Reduce CRISPR Off-target Effects by Synthetic Switch and Self-Restricting Cas9. 2018 BEST Conference & International Symposium on Biotechnology and Bioengineering, Taipei, Taiwan.

  27. Hu, Y.-C*. 2018 May. Roles of RNA therapeutics and CRISPR systems for stem cell engineering and tissue regeneration. Invited speaker. 19th International Meeting of the Korean Tissue Engineering and Regenerative Medicine Society (KTERMS). Seoul, Korea.

  28. Hu, Y.-C*. 2018 Jan. Roles of chemical engineers in metabolic and tissue engineering. Invited speaker. Bowie Science Conference. Hsinchu, Taiwan.

  29. Hu, Y.-C*. 2017 Nov. RNA therapeutics and anabolic gene delivery for tissue regeneration. Plenary speaker. 3rd National Congress on Regenerative Medicine, Moscow, Russia.

  30. Hu, Y.-C*. 2017 Oct. RNA therapeutics and anabolic gene delivery for tissue regeneration. Invited speaker, 2017 International Conference on Biofabrication (BF2017).  Beijing, China.

  31. Hu, Y.-C*. 2017 Sep. RNA therapeutics and anabolic gene delivery for tissue regeneration. 2017 TERMIS-AP meeting. Keynote speaker, Nantong, China.

  32. Hsu, M.-N., Hu, Y.-C*. 2017 Sep. Baculovirus-engineered adipose stem cell sheet persistently expressing GDNF enhance sciatic nerve regeneration. 2017 TERMIS AP, Nantong, China.

  33. Truong, Vu A., Li, K.-C., Chang, Y.-H, Hu, Y.-C*. 2017 Sep. Using baculovirus-mediated miR-214 sponges switch osteoporotic ASCs from adipogenesis to osteogenesis for osteoporotic bone defects repair. 2017 TERMIS AP, Nantong, China.

  34. Hu, Y.-C*. 2017 Sep. RNA therapeutics and anabolic gene delivery for tissue regeneration. The third international conference: Innovations in cancer research and regenerative medicine. Invited speaker, Ho Chi Minh City, Vietnam.

  35. Hu, Y.-C*. 2017 Aug. RNA therapeutics and anabolic gene delivery for tissue regeneration. 2017 International Symposium of Materials on Regenerative Medicine (ISOMRM). Plenary speaker. Chunli, Taiwan.

  36. C.-C., Shen, L.-Y., Sung, M.-W., Lin, Hu, Y.-C*. 2017 July. CRISPR interference (CRISPRi) system for CHO cell engineering and product yield improvement. 2017 Asian Congress of Biotechnology (ACB 2017). Khon Kaen, Thailand.

  37. L.-Y., Sung, Yi, Tu, H. Tu, Hu, Y.-C*. 2017 July. Development of a CRISPR/CRISPRi hybrid system for metabolic engineering of E. coli and succinate production. 2017 Asian Congress of Biotechnology (ACB 2017). Khon Kaen, Thailand.

  38. Hu, Y.-C*. 2017 July. RNA therapeutics and anabolic gene delivery for tissue engineering and regenerative medicine. 2017 Asian Congress of Biotechnology (ACB 2017). Invited speaker, Khon Kaen, Thailand.

  39. Hu, Y.-C*. 2017 June. RNA therapeutics and anabolic gene delivery for tissue engineering and regenerative medicine. Keynote speaker. Davos, Switzerland.

  40. Hu, Y.-C*. 2017 June. RNA therapeutics and anabolic gene delivery for tissue regeneration. 18th International Meeting of the Korean Tissue Engineering and Regenerative Medicine Society (KTERMS). Plenary speaker. Daegu, Korea.

  41. Li, H., Hu, Y.-C*. 2017 Jun. CRISPR/Cas9 for the genome engineering of cyanobacteria and succinate production. 2017 BEST Conference International Symposium on Biotechnology and Bioengineering, Yunlin, Taiwan.

  42. C.-C., Shen, L.-Y., Sung, M.-W., Lin, Hu, Y.-C*. 2017 Jun. CRISPR interference (CRISPRi) system for CHO cell engineering and product yield improvement. 2017 BEST Conference International Symposium on Biotechnology and Bioengineering, Yunlin, Taiwan.

  43. Truong, Vu A., Li, K.-C., Chang, Y.-H, Hu, Y.-C*. 2017 Jun. Using baculovirus-mediated miR-214 sponges switch osteoporotic ASCs from adipogenesis to osteogenesis for osteoporotic bone defects repair. 2017 BEST Conference International Symposium on Biotechnology and Bioengineering, Yunlin, Taiwan.

  44. M.-W., Lin, Hu, Y.-C*. 2017 May. Incorporating synthetic circuits into baculovirus vector for stringent control of miRNA and apoptosis-inducing gene expression in hepatocellular carcinoma cells in vitro and in vivo. Washington DC, USA.

  45. Hu, Y.-C*, K.-C. Li, M.-N., Hsu, M.-W., Lin. 2017 May. Baculovirus-mediated miR-214 suppression shifts osteoporotic ASCs differentiation towards osteogenesis and improves osteoporotic bone defects repair. Washington DC, USA.

  46. Hu, Y.-C*. 2017 April. Bacterial Engineering and Production of Chemicals using CRISPR Technology. 2017 KSBB Spring Meeting and International Symposium. Invited speaker. Gyeongju, Korea.

  47. Hu, Y.-C*. 2017 March. CRISPR technology for microorganism engineering and production of chemicals. 82nd Annual Meeting of Society of Chemical Engineers, Japan. Invited speaker. Tokyo, Japan.

  48. Hu, Y.-C*. 2016 Dec. CRISPR-Cas9 for the engineering of microorganisms and production of chemicals. International Conference on Applied Microbiology. Invited speaker. Ho Chi Minh City, Vietnam.

  49. Hu, Y.-C*. 2016 Nov. 3rd International Symposium of Tissue Engineering and Regenerative Medicine. Delivery of miRNA Therapeutics and Anabolic Genes for Bone Engineering. Plenary speaker. Suwon, Korea.

  50. Li, H., Shen, C.R., Huang, C.-H., Sung, L.-Y., Wu, M.-Y., Chung, M-E., Yeh, I-H., Hu, Y.-C.*. 2016, Nov. CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production. AICHE Annual Meeting. San Francisco, USA.

  51. Li, H., Hu, Y.-C*. 2016 Nov. CRISPR/Cas9 for the genome engineering of cyanobacteria and succinate production. 63rd TwICHE Annual Conference, Taoyuan, Taiwan.

  52. Hsu, M.-N., Hu, Y.-C*. 2016 Nov. Baculovirus-engineered adipose stem cell sheet persistently expressing GDNF enhance sciatic nerve regeneration. 63rd TwICHE Annual Conference, Taoyuan, Taiwan.

  53. Truong, Vu A., Li, K.-C., Chang, Y.-H, Hu, Y.-C*. 2016 Nov. Using baculovirus-mediated miR-214 sponges switch osteoporotic ASCs from adipogenesis to osteogenesis for osteoporotic bone defects repair. 63rd TwICHE Annual Conference, Taoyuan, Taiwan.

  54. Hu, Y.-C*. 2016 Sep. Delivery of miRNA therapeutics and anabolic genes for bone and cartilage engineering. 2016 TERMIS-AP meeting, Keynote speaker, Tamsui, Taiwan.

  55. Truong, Vu A., Li, K.-C., Chang, Y.-H, Hu, Y.-C*. 2016 Sep. Using baculovirus-mediated miR-214 sponges switch osteoporotic ASCs from adipogenesis to osteogenesis for osteoporotic bone defects repair. 2016 TERMIS-AP meeting, Tamsui, Taiwan.

  56. Hsu, M.-N., Hu, Y.-C*. 2016 Sep. Baculovirus-engineered adipose stem cell sheet persistently expressing GDNF enhance sciatic nerve regeneration. 2016 TERMIS-AP meeting, Tamsui, Taiwan.

  57. Hu, Y.-C*. 2016 Aug. Roles of chemical engineers in biomedical and biochemical engineering.  2016, Aug.  The 10th Annual Meeting of Chinese Biochemical Engineering Society. Plenary speaker. Harbin. China.

  58. Li, K.-C., Chang, Y-C., Hu, Y.-C*. 2016 June. Delivery of miRNA therapeutics and anabolic genes for bone and cartilage engineering. Keynote speaker. 2016 TERMIS-EU meeting, Uppsala, Sweden.

  59. Hu, Y.-C*. 2016 June. Roles of chemical engineers in biomedical and biochemical engineering.  2016, June. The 21th Biotechnology and Biochemical Engineering Society of Taiwan (BEST) conference. Plenary speaker. Chung-Li. Taiwan.

  60. Li, H., Hu, Y.-C*. 2016 June. CRISPR/Cas9 for the genome engineering of cyanobacteria and succinate production. Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  61. 1.      Li, H., Hu, Y.-C*. 2016 June. Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9., Metabolic Engineering 11. 2016. Kobe, Japan.

  62. Hsu, M.-N., Hu, Y.-C*. 2016 June. Baculovirus-engineered adipose stem cell sheet persistently expressing GDNF enhance sciatic nerve regeneration. Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  63. Lin, G.-C., Hu, Y.-C*. 2016 June. Graphene oxide for cancer therapy: Studies of mechanism and applications. Biotechnology and Biochemical Engineering Society of Taiwan 2016. Taoyuan, Taiwan.

  64. Li, H., Hu, Y.-C*. 2016 June. CRISPR/Cas9 for the genome engineering of cyanobacteria and succinate production.  Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  65. Lo S.-C., Hu, Y.-C*. 2016 June. The critical-size calvarial defect repair using baculovirus-engineered ASCs co-express BMP-2 and SDF1. Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  66. Huang, C.-H., Hu, Y.-C*. 2016 June. Regulation of gene expression by CRISPRi system in S. elongatus PCC7942. Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  67. Wu, M.-Y., Hu, Y.-C*. 2016 June. Modulation of gene network using CRISPR and CRISPRi for 1, 4-Butanediol production. Biotechnology and Biochemical Engineering Society of Taiwan 2016 Taoyuan, Taiwan.

  68. Lin, G.-C., Tuan, H.-Y., Chen, G.-Y., Hu, Y.-C*. 2016 Apr. Graphene oxide: biological responses and applications. KSBB-BEST Joint Symposium. Invited speaker. Gyeongju, Korea.

  69. Lin, G.-C., Tuan, H.-Y., Chen, G.-Y., Hu, Y.-C*. 2016 Apr. Graphene oxide: biological responses and applications. EMN Meeting on Biomaterials 2016.  Keynote Speaker.  Phuket. Thailand.

  70. Hu, Y.-C*. 2016 Mar. Gene therapy meets cell therapy: Applications in regenerative medicine. Japanese Society for Regenerative Medicine 2016. Invited Speaker. Osaka, Japan.

  71. Lo S.-C., Hu, Y.-C*. 2016 Mar. Repair of Critical Size Calvarial Defects Using Adipose-Derived Stem Cell Modulated with miRNA. Japanese Society for Regenerative Medicine 2016. Osaka, Japan.

  72. Li, K.-C., Hu, Y.-C*. 2016 Mar. Baculovirus-Mediated miR-214 Sponges Switch Osteoporotic ADSCs from Adipogenesis to Osteogenesis and Repair Osteoporotic Bone Defects. Japanese Society for Regenerative Medicine 2016. Osaka, Japan.

  73. Hsu, M.-N., Hu, Y.-C*. 2016 Mar. ASCs Sheet Transduced with Baculovirus GDNF Expression Vector Enhance Sciatic Nerve Regeneration. Japanese Society for Regenerative Medicine 2016. Osaka, Japan.

  74. Hu, Y.-C*. 2015 Nov. Engineering mesenchymal stem cells for cartilage and bone regeneration. Invited speaker and session chair, BIT's 8th World Congress of Regenerative Medicine & Stem Cell

  75. Hu, Y.-C*. 2015 Nov. Versatile gene delivery vectors for sustained transgene expression and applications in regenerative medicine. Invited speaker and session chair. 12th Asian Congress on Biotechnology (ACB 2015). Kuala Lumpur, Malaysia.

  76. Hu, Y.-C*. 2015 Oc. Gene therapy meets cell therapy: Applications in regenerative medicine. Plenary speaker and advisory board member. The 2nd International Conference in Chemical Engineering, Food and Biotechnology-ICCFB2015, Plenary Speaker. Ho Chi Minh City, Vietnam.

  77. Hu, Y.-C*. 2015 Oct. Gene therapy meets cell therapy: Applications in regenerative medicine. Keynote speaker and session chair. The 8th Sino-US Joint Conference of Chemical Engineering. Invited Speaker. Shanghai, China.

  78. Li, K.-C., Chang, Y.-H., Hu, Y.-C*. 2015 Sep. Healing of osteoporotic bone defect by genetically engineered osteoporotic BMSCs expressing MicroRNA sponge. 2015 TERMIS World Congress. Boston. USA.

  79. Hu, Y.-C*. 2015 June. Development of virus-like particle vaccine against enterovirus 71. Invited speaker. 20th Annual Conference of the Chinese Biopharmaceutical Association-USA, LianYunGang, Jiangsu, China.

  80. Li, K.-C., Chang, Y.-H., Hu, Y.-C*. 2015 May. The use of osteoporotic BMSCs engineered by baculovirus-mediated microRNAs sponge to heal osteoporotic bone defect. Invited Speaker. 6th AFOB Regional Symposium. Depok, Indonesia.

  81. Li, K.-C., Chang, Y.-H., Hu, Y.-C*. 2015 May. The use of osteoporotic BMSCs engineered by baculovirus-mediated microRNAs sponge to heal osteoporotic bone defect. 18th Annual Meeting of American Society of Gene and Cell Therapy. New Orleans. USA.

  82. Hu, Y.-C*. 2015 March. Development of hybrid baculoviruses for sustained expression: Applications in regenerative medicine and cancer therapy. Invited speaker, ISBiotech 5th Annual Meeting. Washington DC, USA.

  83. Lin, S-.Y., Chung, Y.-C., Hu, Y.-C*. 2014 Nov.  Development of recombinant baculovirus for high yield production of enterovirus 71 virus-like particle vaccine. 2014 Annual Meeting of AIChE. Atlanta, USA.

  84. Hu, Y.-C*. 2014 Nov. Development of enterovirus 71 vaccine: From expression system design to production, purification and animal experiments. Invited Speaker. 5th International Symposium on Innovative Bioprocess (i-Biot). Tainan, Taiwan

  85. Yeh, C.-L., Li, K.-C., Chang, Y.-H., Hu, Y.-C.*. 2014 Nov.  Genetically modified ASCs that persistently expressed antimicrobial peptides for the treatment of osteomyelitis. 7th World Congress of Preventive and Regenerative Medicine. Taipei, Taiwan.

  86. Li, K.-C., Yeh, C.-L., Chang, Y.-H., Hu, Y.-C.*. 2014 Nov.  The use of bone marrow stromal cells modulated by baculovirus-mediated microRNAs sponge to repair osteoporotic bone defects. 7th World Congress of Preventive and Regenerative Medicine. Taipei, Taiwan.

  87. Hu, Y.-C*.  2014 Oct. Genetic engineering and biotechnology applications-Roles of chemical engineers. 2014 Cross-strait Chemical Engineering Conference. Dalian, China. (Invited speaker)

  88. Hu, Y.-C*.  2014 Sep. Baculovirus-mediated gene delivery for tissue engineering. 2014 TERMIS-AP meeting. Daegu, Korea (Keynote speaker and session chair).

  89. Yeh, I.-H., Chung, M.-E., Hu, Y.-C. 2014 Sep. High-level expression of secretive endoglucanase in Escherichia coli via chromosomal integration. 2014 SBJ 66th Annual meeting. Sapporo, Japan.

  90. Lin, H.-Y., Lin, L.-L., Kao, Y.-C., Hung, C.-L., Lin, S.-Y., Hu, Y.-C. 2014 Sep. Production of porcine circovirus type 2 capsid protein as virus-like particle vaccine by using baculovirus/insect cell expression system. 2014 SBJ 66th Annual meeting. Sapporo, Japan.

  91. Lin, K.-C., Meng, C.-L., Chen, G.-C., Tuan, H.-Y., Hu, Y.-C. 2014 Sep. GO Enhances autophagy, nuclear transport of cisplatin and cancer cell necrosis and exerts anti-tumor effects. 2014 SBJ 66th Annual meeting. Sapporo, Japan.

  92. Chung, M-E., Yeh, I-H., Hu, Y-C., Hu, Y.-C. 2014 Sep. Long-term PHB expression in E. coli using CRISPR/Cas9 gene editing system and CICHE method. 2014 SBJ 66th Annual meeting. Sapporo, Japan.

  93. Lin, S-.Y., Hu, Y.-C*. 2014 July. Development of recombinant baculovirus for high yield production of enterovirus 71 virus-like particle vaccine. 16th European Congress of Biotechnology. Edinburgh, United Kingdom.

  94. Chen, C.-L., Chen, G.-Y., Tseng, Y.-W., Lin, K.-C., Hu, Y.-C. 2014 June. Baculovirus-mediated PTENP1 long non-coding RNA modulation for human hepatocellular carcinoma (HCC) therapy. 19th BEST Conference on Biotechnology and Bioengineering. Taichung, Taiwan.

  95. Lin, S.-Y., Chung, Y.-C., Hu, Y.-C. 2014 June. Development of recombinant baculovirus for high yield production of enterovirus 71 virus-like particle vaccine. 2014 Virus-like particle & nano-particle vaccines. La Jolla, CA, USA.

  96. Yeh, C.-L., Li, K.-C., Chang, Y.-H., Hu, Y.-C. 2014 June. Genetically modified ASCs that persistently expressed antimicrobial peptides for the treatment of osteomyelitis. 19th BEST Conference on Biotechnology and Bioengineering. Taichung, Taiwan.

  97. Chen, C.-L., Yuan, P.-H., Chen, G.-Y., Li, K.-C., Hu, Y.-C. 2014 May. Baculovirus-mediated miR-122 and miR-151 modulation suppresses Mahlavu cell proliferation/migration in vitro and tumor growth in vivo. 17th Annual Meeting of American Society Gene and Cell Therapy (ASGCT). Washington DC, USA.

  98. Yeh, C.-L., Li, K.-C., Chang, Y.-H., Hu, Y.-C. 2014 May. Genetically modified ASCs that persistently expressed antimicrobial peptides for the treatment of osteomyelitis. 17th Annual Meeting of American Society Gene and Cell Therapy (ASGCT). Washington DC, USA.

  99. Li, K.-C., Yeh, C.-L.,Chang, Y.-H., Hu, Y.-C. 2014 May. Healing of osteoporotic bone defects using bone marrow stromal cells modulated by baculovirus-mediated MicroRNAs sponge. 17th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT), Washington, DC, USA

  100. Sung, L.-Y., Hu, Y.-C. 2014 May. Efficient genome editing in mammalian cells using a CRISPR/Cas9 hybrid baculoviral vector. 17th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT), Washington, DC, USA.

  101. Hu, Y.-C.*. 2014 March. Baculovirus as a tool for vaccine development. ISBiotech 4th Annual Meeting. Washington DC, USA. (Invited Speaker)

  102. Hu, Y.-C.*. 2013 Nov. The Baculovirus-engineered adipose-derived stem cells for bone defect repair in the porcine model: Preclinical safety evaluation.  60th Annual Meeting of Taiwan Institute of Chemical Engineers. Taipei, Taiwan. (Invited speaker)

  103. Hu, Y.-C.*. 2013 Nov. Regenerating articular cartilages by genetically engineered ASCs: Prolonged TGF-b3/BMP-6 expression improved chondrogenesis, matrix deposition, mechanical properties and restored zonal structure. 2013 Annual Meeting of AIChE. San Franscisco, USA.

  104. Hu, Y.-C.*. 2013 Oct. Boone and cartilage tissue engineering. 2013 Cross-strait Chemical Engineering Conference. Zhongli, Taiwan. (Invited speaker)

  105. Hu, Y.-C.*. 2013 Oct. Regenerating articular cartilages by genetically engineered ASCs: Prolonged TGF-b3/BMP-6 expression improved chondrogenesis, matrix deposition, mechanical properties and restored zonal structure. 2013 TERMIS-AP meeting. Wuzhen, China. (Keynote speaker)

  106. Hu, Y.-C.*. 2013 Oct. Gene therapy for cartilage and bone tissue engineering. The 7th Sino-US Joint Conference of Chemical Engineering. Beijing, China. (Invited speaker)

  107. Li, K.-C., Yeh, C.-L., Liao, Y.-H., Hu, Y.-C. 2013 October. The adipose-derived stem cells engineered by baculovirus for bone defect repair in the porcine model: preclinical safety evaluation. 2013 TERMIS-AP meeting. Shanghai, China.

  108. Yeh, C.-L., Li, K.-C., Chang, Y.-H., Hu, Y.-C. 2013 October. Genetically modified ASCs expressing antimicrobial peptide for the treatment of osteomyelitis. 2013 TERMIS-AP meeting. Shanghai, China.

  109. Liao, Y.-H., Hu, Y.-C. 2013 October. Repair of critical size calvarial defects using adipose-derived stem cell modulated with miRNA. 2013 TERMIS-AP meeting. Shanghai, China.

  110. Chen, C.-L., Yuan, P.-H., Li, K.-C., Chen, G.-Y., Hu, Y.-C. 2013 September. Simultaneous modulation of miR-122 and miR-151 suppressed hepatocellular carcinoma cell proliferation/migration in vitro and tumor growth in vivo. 2013 SBJ 65th Annual meeting. Hiroshima, Japan.

  111. Chen, G.-Y., Tuan, H.-Y., Hu, Y.-C. 2013 June. Simultaneous induction of autophagy and Toll-like receptor signaling pathways by graphene oxide. Cold Spring Harbor Asia (CSHAsia) 2012 Conference on Vaccine Design, Suzhou, China.

  112. Li, K.-C., Hu, Y.-C. 2013 June. Preclinical safety evaluation of adipose-derived stem cells engineered by baculovirus for bone defect repair in the porcine model. 2013 TERMIS-EU meeting. Istanbul, Turkey.

  113. Lin, C.-Y., Lu, C.-H., Li, K.-C., Chang, Y.-H., Hu., Y.-C. 2013 June. Calvarial bone healing augmented by ASC/Gelatin sponge constructs persistently expressing growth factor. 2013 TERMIS-EU meeting. Istanbul, Turkey.

  114. Hu, Y.-C.*. 2013 Mar. Baculovirus as a versatile gene delivery Vector for bone and cartilage tissue engineering.  ISBiotech 3rd Annual Meeting. Rosslyn, VA, USA. (Invited Speaker)

  115. Hu, Y.-C.*. 2013 Mar. Graphene oxide: Biological responses and applications. 76th Society of Chemical Engineering, Japan (SCEJ) Annual Meeting. Osaka, Japan. (Invited Speaker)

  116. Chen, G.-Y., Hwang, S.-M., Su, H.-J., Hu, Y.-C.*. 2012 Nov. The cellular responses of human mesenchymal stem cells and induced pluripotent stem cells to baculoviral vector transduction. The 13th Federation of Asian and Oceanian Biochemists and Molecular Biologists Congress, Bangkok, Thailand.

  117. Sung, L.-Y., Hu, Y.-C*. 2012 Nov. Engineering of hybrid baculoviral vector for prolonged transgene expression. 59th Annual Meeting of Taiwan Institute of Chemical Engineers. Taichung, Taiwan.

  118. Chen, C.-L., Yuan, P.-S., Hu, Y.-C.* 2012 Nov. Baculovirus-mediated miRNA regulation for the modulation of heptocellular carcinoma cell behavior. 59th Annual Meeting of Taiwan Institute of Chemical Engineers. Taichung, Taiwan. (Invited speaker)

  119. Hu, Y.-C.* 2012 Oct. When gene therapy meets cell therapy: Applications in bone tissue engineering. 2012 Annual Meeting of AIChE. Pittsburgh, USA. (Invited Speaker)

  120. Hu, Y.-C.* 2012 Oct. When gene therapy meets cell therapy: Applications in bone tissue engineering. ISABE meeting. Guiling, China. (Invited Speaker)

  121. Hu, Y.-C. 2012 Sep. Regeneration and revitalization of massive bone defects by genetically engineered ASCs. Crete, Greece.

  122. Hu, Y.-C. 2012 Aug. When cell therapy meets baculovirus-mediated gene therapy: Applications in tissue engineering. The 24th International Congress of Entomology, Daegu, South Korea. (Keynote Speaker)

  123. Chen, G.-Y., Hu, Y.-C.*. 2012 Aug. Cellular responses to BV transduction in human mesenchymal stem cells and induced pluripotent stem cells. The 24th International Congress of Entomology, Daegu, South Korea. (Travel Award)

  124. Lu, C.-H., Hu, Y.-C.* 2012 May.  Baculovirus as a vector for genetic modification of adipose-derived mesenchymal stem cells and its applications in cartilage tissue engineering.  16th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT). Philadelphia, USA.

  125. Sung, L.-Y., Hwang, S.-M., Hu, Y.-C.* 2012 May. Development of a recombinase-based hybrid baculoviral vector for sustained transgene expression. 16th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT). Philadelphia, USA.

  126. Luo, W.-Y., Lo, K.-W., Hung, C.-L., Hu, Y.-C.* 2012 May.  Baculovirus administration triggered adaptive immune response and hindered the subsequent transgene expression.  16th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT). Philadelphia, USA.

  127. Chen, G.-Y., Hu, Y.-C.*. 2012 May. Development of enterovirus 71 virus-like particle vaccine. 2012 Joint Presentation on Biomedical Technology Achievement – NTHU, NCTU, ATIT & NHRI. Hsihchu, Taiwan.

  128. Hu, Y.-C. 2012. March. Development of baculovirus for gene delivery: applications in tissue engineering and vaccine development”. 75th Annual Meeting of Society of Chemical Engineering, Japan. Tokyo, Japan. (Invited Speaker)

  129. Lin, S.-Y., Chung, C.-Y., Chung, Y.-C., Chiu, H.-Y., Hu, Y.-C.*. 2012, Feb 21-24. Development of enterovirus 71 vaccine based on virus-like particles. 14th Asia Pacific Confederation of Chemical Engineering. Singapore.

 

D. 專利

  1. 胡育誠、陳品諺，田庭綸。自組裝奈米粒子、其製備方法及醫藥組合物(SELF-ASSEMBLING NANOPARTICLE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION)。中華民國發明專利申請中. 申請日: 2024/6/5.

  2. 胡育誠、范玉南,周俊彥, 王興運, 劉珈男. 維斯假絲酵母的基因編輯系統、其基因編輯方法、生產十二烷二酸的轉型株及生產十二烷二酸的方法. 中華民國發明專利申請中. 申請日: 2022/9/29.

  3. 胡育誠、范玉南,周俊彥. 維斯假絲酵母的基因編輯系統、其基因編輯方法及其應用. 中國發明專利申請中. 申請日: 2022/9/29.

  4. 胡育誠,張晉維, 黃靖雯, 周俊彥. 大腸桿菌基因編輯系統及其基因編輯方法. 中華民國發明專利申請中. 申請日: 2022年01月26日

  5. 胡育誠,張晉維, 黃靖雯, 周俊彥. 大腸桿菌基因編輯系統及其基因編輯方法. 中國發明專利申請中. 申請日: 2022年01月26日.

  6. Yu-Chen Hu, Ngoc-Nam Pham, Jun-Yen Chou, Hsing-Yun Wang, Jianan Liu. Gene Editing System of Candida viswanathii, gene editing method thereof. Transformant for producing dodecanedioic acid and method for producing dodecanedioic acid. US patent filed on 2023/03/24.

  7. Yu-Chen Hu, Chin-Wei Chang, Chin-Wen Huang, Jun-Yen Chou. Gene editing system of Escherichia coli and gene editing method thereof. US patent filed on 2022/08/04. US-2023-0235338-A1.

  8. Yu-Chen Hu, Yenlin Chen, Hung-Ming Chang. Microbial composition and processing method for wastewater. US patent application filed.

  9. Yu-Chen Hu, Yenlin Chen, An-Banh Du. Black yeast Aureobasidium melanogenum strain and method of producing succinic acid using the same.  US patent application filed.

  10. Yu-Chen Hu, Chih-Che Shen. System for over-expressing target protein and method for over-expressing target protein. US patent application published (US-2018-0282759-A1).

  11. Yu-Chen Hu, Hung Li, Jun-Hung Huang, Li-Yu Sung, Chih-Che Shen. Gene expression regulation system of Synechococcus elongates PCC 7942 and application thereof. China patent application filed.

  12. Yu-Chen Hu, Hung Li, Jun-Hung Huang, Li-Yu Sung, Chih-Che Shen. Gene expression regulation system of Synechococcus elongates PCC 7942 and application thereof.  US patent application filed.

  13. Yu-Chen Hu, Ngoc-Nam Pham, Cho-Yi Chen, June-Yen Chou.  Transformant for producing 2,5-Furandicarboxylic acid and preparation method for 2,5-furandicarboxylic acid. US 11578346B2. 2023/02/14-2040/12/01 (extendable to 2041/08/19)

  14. 胡育誠, 范玉南, 陳倬翊, 周俊彥. 戀臭假單胞菌S12基因編輯系統及其應用. 中華民國發明專利I739247. (專利權有效期間:2021/09/11~ 2039/12/19)

  15. 胡育誠, 范玉南, 陳倬翊, 周俊彥. 2,5-呋喃二甲酸之製備方法. 中華民國發明專利I735113. (專利權有效期間:2021/08/01~ 2039/12/22)

  16. 胡育誠, 陳彥霖, 張鴻銘. Microbial composition and processing method for wastewater. 微生物組合物及廢水處理方法. 中華民國發明專利. I710632 (專利權有效期間: 2020/11/21~ 2039/09/11).

  17. Yu-Chen Hu, Mu-En Chung, I-Hsin Yeh, Hung, Li. Method for bacterial genome editing細菌基因編輯方法. 中國發明專利. CN 106609279 B (專利有效期間: 2020/08/14 ~ 2036/10/21).

  18. Yu-Chen Hu, Hung Li, Jun-Hung Huang, Li-Yu Sung, Chih-Che Shen. 細長聚球藻PCC7942之基因編輯系統及其應用. 中華民國發明專利. I643951 (專利有效期間: 2018/12/11~2036/08/01)

  19. Yu-Chen Hu, Hung Li, Jun-Hung Huang, Li-Yu Sung, Chih-Che Shen. Gene expression regulation system of Synechococcus elongates PCC 7942 and application thereof. 細長聚球藻PCC 7942之基因表現干擾系統以及抑制細長聚球藻PCC 7942基因表現之方法. 中華民國發明專利 I629358. (專利有效期間: 2018/07/11-2036/08/01)

  20. Yu-Chen Hu, Mu-En Chung, I-Hsin Yeh, Hung, Li, Li-Yu Sung. Cas9 plasmid, genome editing system and method of Escherichia coli.  US patent. US 9988637B2. 2018/06/05-2036/03/10.

  21. Yu-Chen Hu, Chih-Che Shen. 大量表現目標蛋白系統及其方法System for over-expressing target protein and method thereof. 中華民國發明專利. I626309. (專利有效期間: 2018/06/11-2037/03/30).

  22. Yu-Chen Hu, Yenlin Chen, An-Banh Du. 黑酵母菌出芽短梗黴Aureobasidium melanogenum菌株及利用其生產琥珀酸的方法 (Black yeast Aureobasidium melanogenum strain and method of producing succinic acid using the same).  中華民國發明專利. I592482. (專利有效期間: 2017/07/21-2036/12/25).

  23. Yu-Chen Hu, Mu-En Chung, I-Hsin Yeh, Hung, Li, Li-Yu Sung. Cas9 expression plasmid, gene editing system of Escherichia coli and application thereof. 中華民國發明專利 I608100. (專利有效期間: 2017/12/11-2037/02/02).

  24. Yu-Chen Hu, Guan-Yu Chen, Hsing-Yu Tuan. Method for inducing autophagy and activating toll-like receptor. US Patent. US 9421224B2.  2016/08/23-2035/04/17.

  25. Yu-Chen Hu, Shih-Yeh Lin.  Method for preparing virus-like particle and recombinant baculovirus used therein. US Patent. US 9388390B2. 2016/07/12-2035/03/24.

  26. 胡育誠, 林事曄. 類病毒顆粒的製備方法及其使用的重組桿狀病毒.中華民國發明專利I558812. (專利有效期間: 2016/11/21-2032/03/19).

  27. 胡育誠, 陳繼元. “桿狀病毒表現載體與其應用”. 中華民國發明專利. I411681. (專利有效期間: 20131011-20290817).

  28. 劉宏仁, 林岳宏, 胡育誠. “泛用型桿狀病毒表面呈現系統及其應用於次單位疫苗之製備”(A universal baculovirus surface display system and application in production of subunit vaccine) 中華民國發明專利. I368656.

  29. 胡育誠. “腸病毒類病毒顆粒的製備方法及其應用”. 中華人民共和國發明專利 CN101928728A. 2013/03/27-2033/03/26.

  30. Yu-Chen Hu, Chi-Yuan Chen. “Baculovirus expression vector and method therewith for generating immunogenicity in a host”. US patent, US 8399246B2. 2013/03/19-2031/03/04.

  31. Yu-Chen Hu, Wen-Hsin Lo. “Method for sustained expression of an exogenous gene”. US patent, US 8110183B2. 2012/02/07-2028/12/11.

  32. 胡育誠, 羅文鑫. “長期表現外源基因之方法”. 中華民國發明專利I349037. (專利有效期間: 2011/09/21-2028/08/03).

  33. 胡育誠, 陳皇綺, 廖俊仁 “組織細胞培養生物反應器”, 中華民國發明專利I294912. (專利有效期間: 2008/03/21-2025/04/03)

  34. 廖俊仁, 李筱萍, 胡育誠, 江淑芳 “生物反應器”,中華民國發明專利I238851. (專利有效期間: 2005/09/01-2023/12/30)

 

E. 其他

1.     林進裕，胡育誠, “醫生的助手”, 科學發展月刊, 464 期(8月), pp 26-33 (2011).

2.     胡育誠, “以桿狀病毒轉導之脂肪、硬骨與軟骨前驅細胞:轉導效率與細胞分化狀態關聯性之探討與在組織工程之應用”, 工程科技通訊, 第102期(9月), pp 120-123 (2009).

3.     陳冠宇, 胡育誠, “管柱層析法在病毒基因載體純化上的應用”, 化工, 第51 卷第5 期(5月), pp 1-10 (2009).

4.     胡育誠, “以桿狀病毒做為基因載體在軟骨組織工程之應用:軟骨細胞於平面與反應器內培養之最佳感染條件與在反應器中培養感染後軟骨組織之探討”, 工程科技通訊, 第89 期(12 月), pp 72-77 (2006).

5.     胡育誠, “以桿狀病毒製備腸病毒七十一型類病毒粒子:特性與下游程序探討”, 工程科技通訊, 第82 期(10 月), pp 85-88 (2005).

6.     李筱萍, 胡育誠, “基因工程及與生技產品”, 化工, 第51 卷第5 期(10 月), pp 2-7 (2004).

7.     陳皇綺, 胡育誠, “動物細胞”, 化工, 第51 卷第5 期(10 月), pp 21-25 (2004).

8.     胡育誠, “基因治療的過去與展望”, 科學發展月刊, 372 期(12 月), pp 42-45 (2002).

9.     胡育誠, ”複製人的迷思”, 科學發展月刊，358期 (10 月), pp 46-51 (2002).

10.  胡育誠, “基因魔術”, 科學發展月刊, 355期 (7 月), pp 30-33 (2002).

REVIEWER FOR INTERNATIONAL JOURNALS

*          Acta Pharmacologica Sinica

*          Acta Biomaterialia

*          Applied Microbiology and Biotechnology

*          Applied Biochemistry and Biotechnology

*          BioEssays

*          Biomaterials

*          Biotechniques

*          Biotechnology and Bioengineering

*          Biotechnology and Applied Biochemistry

*          Biotechnology Progress

*          BMC Medical Genomics

*          Current Gene Therapy

*          Drug Discovery Today

*          Drug Development and Industrial Pharmacy

*          Enzyme and Microbial Technology

*          Expert Review of Vaccines

*          Gene Therapy

*          Journal of Biotechnology

*          Journal of Cellular and Molecular Medicine

*          Journal of the Chinese Institute of Chemical Engineers

*          Journal of Control Release

*          Molecular Therapy

*          Molecular Cancer

*          Nucleic Acids Research

*          Process Biochemistry

*          Scientific Reports

*          The National Medical Research Council (Singapore) grant review (2006-2007, 2010-2012)

*          The NSERC (Canada) grant review (2014)

*          The Polish National Science Center grant review (2013)

*          Recent Patents on Biotechnology

*          Virology